🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
The purpose of this study is to determine if the combination of endocrine t...
Status
Completed
Location
Cross Cancer Institute
Start Date
2016-04-08
Trial ID
NCT02630693
Treatments Being Tested
Although randomized controlled trials (RCTs) provide evidence of efficacy, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-03-15
Trial ID
NCT02753686
The majority of patients (pts) with breast cancer have hormone receptor pos...
Status
Active Not Recruiting
Location
University of Miami
Start Date
2023-06-12
Trial ID
NCT05826964
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Status
Recruiting
Location
Ellison Clinic at Saint John's
Start Date
2023-04-17
Trial ID
NCT05768139
This is a Phase 2 study to demonstrate the safety and efficacy of SFX-01 wh...
Status
Completed
Location
Grand Hopital de Charleroi, Service D'Oncologie-Hematologie
Start Date
2016-10
Trial ID
NCT02970682
Treatments Being Tested
Local treatment in addition to endocrine treatment as 1st line for oligo-me...
Status
Unknown
Location
Gangnam Severance Hospital
Start Date
2018-08-01
Trial ID
NCT03750396
Treatments Being Tested
A assessment of the efficacy of first-/second-line endocrine therapies ± ta...
Status
Unknown
Location
N.N. Blokhin National Medical Research Center of Oncology
Start Date
2021-01-01
Trial ID
NCT04852081
Treatments Being Tested
This is an open-label, single-center, exploratory, Phase Ib/II clinical tri...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-06-23
Trial ID
NCT07708194
Treatments Being Tested
Detection of molecular relapse with circulating tumour DNA analysis can ide...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2022-03-30
Trial ID
NCT04985266
Treatments Being Tested